U.S. Buys All Of July's Production Of Antiviral Drug Remdesivir

The transcript discusses the US acquisition of Remdesivir, an antiviral drug for COVID-19, securing over half a million treatment courses. Concerns arise about potential shortages in other countries. The drug, initially for Ebola, aids COVID-19 recovery but its impact on survival is unclear. Amid rising US COVID-19 cases, experts express concern. Remdesivir treatment costs over $3000, with insurance companies charged $520 per vial.

How much will private insurance companies be charged per vial of the drug?

What is the estimated cost for one treatment course of the drug?